Researchers show CRISPR can selectively destroy cells, a cancer-treatment goal. In journal ‘Nature,’ researchers demonstrate CRISPR-Cas12a2 can be programmed to target unhealthy cells, while sparing healthy cells. In mice, the therapy reduced tumor volume by about 50% after a single treatment.

Researchers show CRISPR can selectively destroy cells, a cancer-treatment goal. In journal ‘Nature,’ researchers demonstrate CRISPR-Cas12a2 can be programmed to target unhealthy cells, while sparing healthy cells. In mice, the therapy reduced tumor volume by about 50% after a single treatment.